FUTURES: efficacy and acceptability of a novel reproductive health education program for adolescent males with sickle cell disease
Blood Adv
.
2023 Nov 14;7(21):6648-6651.
doi: 10.1182/bloodadvances.2023011024.
Authors
Charis J Stanek
1
,
Susan E Creary
1
2
3
,
Sophia M Liles
1
,
Zachary A Colton
1
,
Joseph R Stanek
1
,
Gwendolyn P Quinn
4
,
Toyetta Barnard-Kirk
3
,
Mary Ann Abrams
2
3
,
Leena Nahata
1
2
3
Affiliations
1
The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH.
2
Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH.
3
Nationwide Children's Hospital, Columbus, OH.
4
Department of Obstetrics and Gynecology, NYU Grossman School of Medicine, New York, NY.
PMID:
37672303
PMCID:
PMC10628813
DOI:
10.1182/bloodadvances.2023011024
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Adolescent
Anemia, Sickle Cell* / therapy
Humans
Male
Reproductive Health
Sickle Cell Trait*
Grants and funding
UL1 TR002733/TR/NCATS NIH HHS/United States